Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

Fig. 2

ANC recovery in patients who did not achieve CR. a Percentage of patients with durable (≥ 2 consecutive visits) recovery at any time on study. b Percentage of patients with ANC recovery after the first, second, and third treatment cycle. For treatment cycle analysis, one threshold measurement was required; all patients were included regardless of their BL levels but each cycle only included remaining patients at risk in that cycle. Analysis set, N = number of patients with ANC results in the cycle; patients, n = number of patients meeting recovery criteria in the cycle. Abbreviations: ANC, absolute neutrophil count; BL, baseline; CR, complete remission; LDAC, low-dose cytarabine

Back to article page